MWNA
ARNA

Marshall Wace North America’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Marshall Wace North America’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$23.1M Buy
388,397
+135,649
+54% +$8.01M 0.1% 222
2021
Q2 		$17.2M Sell
252,748
-74,310
-23% -$4.84M 0.07% 284
2021
Q1 		$22.7M Sell
327,058
-110,818
-25% -$8.53M 0.09% 234
2020
Q4 		$33.6M Sell
437,876
-559,520
-56% -$41.9M 0.15% 166
2020
Q3 		$74.6M Sell
997,396
-359,222
-26% -$24M 0.48% 45
2020
Q2 		$85.4M Buy
1,356,618
+863,891
+175% +$47.5M 0.56% 39
2020
Q1 		$20.7M Buy
492,727
+131,969
+37% +$6.05M 0.16% 152
2019
Q4 		$16.4M Buy
360,758
+105,318
+41% +$4.98M 0.08% 224
2019
Q3 		$11.7M Sell
255,440
-15,649
-6% -$880K 0.07% 237
2019
Q2 		$15.9M Sell
271,089
-318,601
-54% -$16.5M 0.1% 177
2019
Q1 		$26.4M Buy
589,690
+168,164
+40% +$7.71M 0.19% 119
2018
Q4 		$16.4M Buy
421,526
+31,027
+8% +$1.22M 0.16% 120
2018
Q3 		$18M Sell
390,499
-333,789
-46% -$13.5M 0.12% 147
2018
Q2 		$31.6M Buy
724,288
+379,881
+110% +$16.3M 0.18% 132
2018
Q1 		$13.6M Buy
+344,407
New +$13.4M 0.07% 328
2017
Q3 		– Sell
-95,888
Closed -$1.63M – 1595
2017
Q2 		$1.63M Buy
+95,888
New +$1.31M 0.01% 799
2013
Q4 		$92K Buy
+1,568
New +$81.9K ﹤0.01% 671

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Marshall Wace North America's ARNA Position: Q3 2021 in Review

Marshall Wace North America increased its Arena Pharmaceuticals Inc (ARNA) stake by 54% in Q3 2021, buying an estimated $8.01M and bringing the position to 388,397 shares worth $23.1M. The position accounts for 0.1% of the portfolio, ranked #222.

Marshall Wace North America first reported a position in ARNA in Q4 2013 and has held it in 17 quarters since. The position peaked at $85.4M in Q2 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q3 2021.

  • Marshall Wace North America held 388,397 shares of Arena Pharmaceuticals Inc worth $23.1M as of Q3 2021.
  • Marshall Wace North America bought 135,649 Arena Pharmaceuticals Inc shares in Q3 2021, an estimated $8.01M.
  • Arena Pharmaceuticals Inc made up 0.1% of Marshall Wace North America's portfolio in Q3 2021, its #222 holding.
  • Marshall Wace North America first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and has held it in 17 quarters since.
  • Marshall Wace North America's Arena Pharmaceuticals Inc position peaked at $85.4M in Q2 2020.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.